Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

New treatments for male hypogonadism are effective and should be personalized.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Finasteride reduces hair growth and is safe for women with excessive hair.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Pharmacists play a crucial role in customizing treatments and ensuring medication safety.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.